{"database": "lobbying", "table": "lobbying_activities", "rows": [[1450636, "8f6524fd-5a19-4815-ab3b-ca71a32d701a", "Q3", "REPUBLIC CONSULTING, LLC", 401016871, "U.S. CHAMBER OF COMMERCE INSTITUTE FOR LEGAL REFORM", 2013, "third_quarter", "TOR", "Help ensure rationality, fairness and more certainty in the legal system; Monitor oversight of studies mandated in section 929Z and 929Y of the Dodd/Frank Wall Street Reform and Consumer Protection Act; Support Securities Litigations Attorney Accountability and Transparency Act (S.652); Support Lawsuit Abuse Reduction Act of 2013 (S.1288); Oppose proposed FDA rule re generic drug labeling; Argue for pre-dispute arbitration", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2013-10-18T11:44:10.580000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1450636"], "units": {}, "query_ms": 4.658995079807937, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}